首页> 美国卫生研究院文献>other >High Specific Activity Tritium-Labeled N-(2-methoxybenzyl)-25-dimethoxy-4-iodophenethylamine (INBMeO): A High Affinity 5-HT2A Receptor-Selective Agonist Radioligand
【2h】

High Specific Activity Tritium-Labeled N-(2-methoxybenzyl)-25-dimethoxy-4-iodophenethylamine (INBMeO): A High Affinity 5-HT2A Receptor-Selective Agonist Radioligand

机译:高比活度t标记的N-(2-甲氧基苄基)-25-二甲氧基-4-碘苯乙胺(INBMeO):高亲和力的5-HT2A受体选择性激动剂放射性配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The title compound ([3H]INBMeO) was prepared by an O,O-dimethylation reaction of a t-BOC protected diphenolic precursor using no carrier added tritiated iodomethane in DMF with K2CO3. Removal of the t-BOC protecting group and purification by HPLC afforded an overall yield of 43%, with a radiochemical purity of 99% and specific activity of 164 Ci/mmol. The new radioligand was suitable for labeling human 5-HT2A receptors in two heterologous cell lines and had about 20-fold higher affinity than [3H]ketanserin.
机译:标题化合物([ 3 H] INBMeO)是通过t-BOC保护的双酚前体的O,O-二甲基化反应制备的,其中不使用在K2CO3中在DMF中添加added代碘甲烷的载体。除去t-BOC保护基并通过HPLC纯化得到43%的总产率,放射化学纯度为99%,比活为164Ci / mmol。新的放射性配体适合在两种异源细胞系中标记人5-HT2A受体,其亲和力比[ 3 H] ketanserin高约20倍。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号